Clinical Trial Update: A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches [Phase 4]

View source ↗

Summary

A terminated Phase 4 double-blind, placebo-controlled trial evaluated Rozerem (ramelteon) for migraine headaches.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Headache

Drugs mentioned

• ROZEREM (ramelteon)

Snippet

Sponsor: Charlottesville Neuroscience | Conditions: Migraine Headache | Phase 4 | Status: TERMINATED